Currently out of the existing stock ratings of Chase Knickerbocker, 71 are a BUY (97.26%), 2 are a HOLD (2.74%).

Chase Knickerbocker

Work Performance Price Targets & Ratings Chart

Analyst Chase Knickerbocker, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 41.57% that have a potential upside of 54.95% achieved within 174 days.

Chase Knickerbocker’s has documented 141 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ETON, Eton Pharmaceuticals at 28-Jul-2026.

Wall Street Analyst Chase Knickerbocker

Analyst best performing recommendations are on IRWD (IRONWOOD PHARMACEUTICALS).
The best stock recommendation documented was for IRWD (IRONWOOD PHARMACEUTICALS) at 10/29/2025. The price target of $1.7 was fulfilled within 2 days with a profit of $0.19 (12.58%) receiving and performance score of 62.91.

Average potential price target upside

of $18.17 (72.71%) on HROW (HARROW HEALTH).
of $9.89 (77.67%) on INDV (INDIVIOR PLC ORDINARY SHARES).
of $8.15 (65.47%) on ETON (ETON PHARMACEUTICALS).

ACST Acasti Pharma AVDL Avadel Pharmaceuticals PLC BFLY Butterfly Network CVRX CVRx DCTH Delcath Systems DMAC DiaMedica Therapeutics ETON Eton Pharmaceuticals FENC Fennec Pharmaceuticals GH Guardant Health HROW Harrow Health INDV Indivior PLC Ordinary Shares IRWD Ironwood Pharmaceuticals KRMD Repro Med Systems MDWD Mediwound Ltd MDXG MiMedx Group PHAT Phathom Pharmaceuticals PYPD PolyPid

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Oren Livnat (HC WAINWRIGHT)